The US has become the second western country to give an emergency use authorisation to a Covid-19 vaccine developed by BioNTech SE in partnership with Pfizer Inc. The vaccine, BNT162b2, is based on messenger RNA (mRNA), a technology never before used in a human vaccine. It was given an emergency authorisation by the Food and Drug Administration on 11 December for individuals 16 years and over.
